期刊
CURRENT OPINION IN IMMUNOLOGY
卷 65, 期 -, 页码 14-20出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2020.01.008
关键词
-
类别
资金
- National Institute of Allergy and Infectious Diseases [1R01AI146101, R01-AI050484, R01-AI124429, R01-AI084860]
- Cancer Research Institute
Messenger RNA (mRNA) vaccines represent a relatively new vaccine class showing great promise for the future. This optimism is built on recently published studies demonstrating the efficacy of mRNA vaccines in combatting several types of cancer and infectious pathogens where conventional vaccine platforms may fail to induce protective immune responses. These results would not have been possible without critical recent innovations in the field, such as the development of safe and efficient materials for in vivo mRNA delivery and advanced protocols for the production of high quality mRNA. This review summarizes the most important developments in mRNA vaccines from the past few years and discusses the challenges and future directions for the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据